Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
Pharmaceutical tariffs: Which countries does the U.S. import the most from?
The U.S. has significant pharmaceutical trade deficits with Ireland, Switzerland, and Singapore.
My Top Dividend-Paying, Deep-Value Stock to Buy in August
You won't find many stocks with a juicier dividend and more attractive valuation than this big pharma stock.
Is Pfizer's 6.8%-Yielding Dividend Too Good to Be True?
Pfizer's yield is high, and so too is its payout ratio.
2 Top Dividend Stocks to Buy on the Dip
These blue chip healthcare stocks could still deliver strong long-term returns.
After a Strong Quarterly Result, Is It Finally Safe to Buy Pfizer Stock Again?
Pfizer beat expectations last quarter and it raised its guidance.
3 Reasons Pfizer's 7%-Yielding Dividend Is Getting Safer
This big pharma company's juicy dividend is looking even more attractive.
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Investing is about looking ahead.
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
It was a rare breath of fresh air for shareholders.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q4 2024 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2024.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.